3,801 companies
6,689 AI summaries
5,620 risk analyses
2,762 growth scores
Register free — watchlist & alerts →
🔔 Get free email alerts on リブ/コンサルティング (4800)
AI summaries of Japanese EDINET filings — in English. Free, unsubscribe anytime.
- ✓ Email alert when 4800 files its next EDINET disclosure
- ✓ AI summary · sentiment · risk · growth (JA / EN)
- ✓ Free account: watchlist & alerts on all the stocks you follow
EDINET 4800 Out of Scope
リブ/コンサルティング
Change Report ／ 2026-07-07 12:00
Covers EDINET statutory filings (TDNET timely disclosures / earnings flashes are not included).
📊 Large-shareholding (5%) report Policy holding
Holder: Ritorupondo
Stake: 31.16%
Change: 0pp increase
Purpose:
The company is an asset management company of the founder and holds shares for the purpose of long-term stability as a shareholder. However, as described in (6) "Important Contracts Related to Pledges, etc. for Such Securities," Submitter 1 entered into a transaction with Media Corporation (hereinafter "Public Acquiror") on May 28, 2026, with the following terms: 1) Not to tender all of Submitter 1's common shares of the issuer (hereinafter "Non-Tendered Shares") in the public tender offer for the issuer's common shares conducted by the Public Acquiror (hereinafter "Public Tender Offer"); 2) T
🧩 5% holders of this company (4 holders · 66.58%)
| Holder | Stake | Change | |
|---|---|---|---|
| Ritorupondo Policy | 31.16% | 0pp | view |
| Media Activist | 27.13% | 0pp | view |
| HIKARI TSUSHIN,INC. Pure | 6.85% | 0pp | view |
| Nomura Securities | 1.44% | new | view |
Each holder’s most recent 5% filing. The sum reflects disclosed major-holder ownership, not total float.
Risk and growth scores and tags are AI-generated estimates from analyzing the disclosure. They are not guarantees of fact, nor investment advice or recommendations. Make investment decisions at your own discretion.
Track Japanese disclosures with JSIGNAL
AI summaries, risk & growth analysis, watchlist alerts and a screener for every Japanese listed company.
Start free — 30-day trial Login